Global Markets

Roche’s (ROG SW) breast cancer pill Wilserdly wins US regulatory approval, Bloomberg reports

ORIGINAL · NewsquawkRoche’s (ROG SW) breast cancer pill Wilserdly wins US regulatory approval, Bloomberg reports
StockNow breaking-news AI analysis

Bloomberg reports that Roche’s breast cancer pill Wilserdly has received US regulatory approval.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more